METABOLIC DISORDERS AND VITILIGO: ASSESSMENT OF THE LEVELS OF VITAMIN D, TRACE ELEMENTS, HOMOCYSTEINE
Main Article Content
Abstract
This study presents a comprehensive assessment of the metabolic profile in patients with vitiligo in order to determine the relationship between the levels of vitamin D, trace elements and homocysteine and the clinical characteristics of the disease. The analysis was carried out by comparing patients with vitiligo and a control group of healthy volunteers. On the basis of biochemical data and clinical indices, the severity of metabolic disorders and their influence on the course of the disease were determined. The levels of vitamin D, zinc, selenium, copper, magnesium and homocysteine were analysed using statistical methods. In addition, key metabolic predictors of disease severity were identified, which is an important indicator for clinical prognosis and the personalisation of therapy.
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Bergqvist C., Ezzedine K. Vitiligo: A Review. Dermatology. 2020;236(6):571–592.
Ezzedine K., Eleftheriadou V., Whitton M., van Geel N. Vitiligo. Lancet. 2015;386(9988):74–84.
Haulrig M.B., et al. The global epidemiology of vitiligo: a systematic review and meta-analysis of the incidence and prevalence. J Invest Dermatol. 2024.
Bibeau K., et al. Mental Health and Psychosocial Quality-of-Life Burden in Patients with Vitiligo. JAMA Dermatol. 2023;159(10):1133–1142.
Nasser M.A.E.M., et al. Stress, anxiety, and depression in patients with vitiligo. Middle East Curr Psychiatry. 2021;28(1):70.
Frisoli M.L., Essien K., Harris J.E. Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol. 2020;38:621–648.
Taïeb A., Picardo M. Clinical practice. Vitiligo. N Engl J Med. 2009;360(2):160–169.
Speeckaert R., et al. Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2018;32(7):1089–1098.
Chang W.-L., Ko C.-H. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications. Cells. 2023;12(6):936.
Schallreuter K.U., Wood J.M., Berger J., et al. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol. 1999;113(6):1081–1085.
Mehaney D.A., et al. Analysis of oxidative stress status, catalase and COMT gene polymorphisms in generalized vitiligo. PLoS One. 2014;9(6):e99286.
Białczyk A., et al. Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review. Drugs in Context. 2023;12:1–17.
Sri A.U., et al. Association of Serum Vitamin D3 Levels With Vitiligo: A Case-Control Study at a Tertiary Care Center. Cureus. 2025;17(1):eXXXXX.
Silverberg J.I., et al. A pilot study assessing the role of 25-hydroxy vitamin D levels in patients with vitiligo. J Am Acad Dermatol. 2010;62(6):AB60.
Vahideh L., et al. Vitamin D serum level in vitiligo patients: a case-control study. Iran J Dermatol. 2014;17(4):123–129.
Babu A.K., et al. A study of 25-hydroxyvitamin D level in vitiligo in Malaysia. J Am Acad Dermatol. 2017;76(6 Suppl 1):AB131.
Bjørklund G., et al. The role of trace elements for the function and health of skin. J Trace Elem Med Biol. 2025;79:127303.
Wacewicz M., et al. Selenium, zinc, copper, Cu/Zn ratio and total antioxidant status in vitiligo. J Dermatolog Treat. 2018;29(2):190–193.
Anam K., et al. Zinc, copper, and selenium levels in vitiligo: a systematic review and meta-analysis. Sci Rep. 2024;14:XXXXX.
Salem M.A., et al. Serum Copper and Zinc Levels in Vitiligo Patients. Egypt J Hosp Med. 2013;53:270–280.
Chen J., et al. Serum homocysteine levels elevated in patients with vitiligo. J Invest Dermatol. 2016;136(5 Suppl):S92.
Tsai T.Y., et al. Serum homocysteine, folate, and vitamin B12 levels in patients with vitiligo. J Am Acad Dermatol. 2019;81(2):AB60.
Choudhary N., et al. A hospital-based case–control study on raised serum homocysteine level among vitiligo patients. J Family Med Prim Care. 2023;12(3):XXXX–XXXX.
Reish O., et al. Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: a mechanism for reversible hypopigmentation in homocystinuria. J Invest Dermatol. 1995;104(1):77–82.